Delivery Order SPE2DB22D2007-SPE2DB25FJ4QA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $67,384.37 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, which is firm fixed price with no set-aside designation, was competitively awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,626.77 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion by July 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $39,049.72 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $138,315.26 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 4, 2025. The contract was competitively awarded with no set-aside designation and employs firm fixed price terms. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,877.52 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's pharmaceutical supply services to federal...
- The Defense Logistics Agency awarded a delivery order valued at $42,776.04 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $33,875.59 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, effective through September 5, 2025. This competitively awarded, firm fixed-price contract requires performance at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor vehicle running...
- The Defense Logistics Agency awarded a $25,765.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of ENBREL 50 MG/ML SureClick auto-injectors. The contract, which represents a child order under a larger procurement vehicle, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 20, 2025. This competitive award, issued on August 19, 2025, carries firm fixed pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4QADelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $75,067.93 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract is firm fixed price with no set-aside designation and is scheduled for completion by September 4, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical commodities to military and federal healthcare systems globally. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, demonstrating extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains. The company has established itself as a reliable partner through its consistent receipt of competitively awarded, non-set-aside contracts with the Defense Logistics Agency's Medical Supply Chain. This specific award for Enbrel, a specialty biopharmaceutical product used in treating inflammatory conditions, reflects AmerisourceBergen's ongoing role in supporting the Defense Health Agency and broader military healthcare operations with essential pharmaceutical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.1k | 9/3/25 |